About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Safety Study of XP12B in Women With Menorrhagia

NCT00113568·59 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Ferring Pharmaceuticals

Age

18–49

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

Women with menorrhagia
18-49 years of age
Regularly occuring menstrual periods

You may not be if

History or presence of clinically significant disease or abnormalities that might confound the study
History of bilateral oophorectomy or hysterectomy

The record

StatusCompleted

PhasePhase 3

Taking part784

StartedJun 2005

UpdatedJun 15, 2010

Conditions

Menorrhagia Heavy Menstrual Bleeding

Where59

Investigative Site
Birmingham, Alabama, United States
Investigative Site
Mobile, Alabama, United States
Investigative Site
Montgomery, Alabama, United States

Clareo Health | Safety Study of XP12B in Women With Menorrhagia